Rothman K J, Louik C
N Engl J Med. 1978 Sep 7;299(10):522-4. doi: 10.1056/NEJM197809072991006.
We reviewed the birth certificates and hospital records of 7723 infants those mothers had reported using oral contraceptives. The overall frequency of malformation was 4.3 per cent for infants whose mothers terminated use of oral contraceptives shortly before conception, as compared with 3.3 per cent for infants whose mothers did not take oral conceptives diring the three years before conception. The 90 per cent confidence limits for the prevalence ratio were 1.0 and 1.7. No difference was apparent for major malformations. For specific malformations the most notable difference was for undescented testis, but this excess, like the overall excess, could be explained by sampling variability. Despite the slightly greater rate of minor malformations in the short-interval group, a reasonable interpretation of these data would be that oral contraceptives present no major teratogenic hazard.
我们查阅了7723名婴儿的出生证明和医院记录,这些婴儿的母亲曾报告使用过口服避孕药。母亲在受孕前不久停止使用口服避孕药的婴儿中,畸形的总体发生率为4.3%,而母亲在受孕前三年未服用口服避孕药的婴儿中,这一比例为3.3%。患病率比值的90%置信区间为1.0至1.7。主要畸形方面没有明显差异。对于特定畸形,最显著的差异在于隐睾,但这种增加,与总体增加情况一样,可能是由抽样变异性造成的。尽管短间隔组的轻微畸形发生率略高,但对这些数据的合理解读是口服避孕药不存在重大致畸风险。